Ixabepilone in Treating Patients With Relapsed and/or Refractory Stage III or Stage IV Ovarian Epithelial or Primary Peritoneal Cancer

Completed · Phase 2

Conditions studied: Ovarian Cancer, Peritoneal Cavity Cancer

In brief

RATIONALE: Drugs used in chemotherapy, such as ixabepilone, work in different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of ixabepilone in treating patients who have relapsed and/or refractory stage III or stage IV ovarian epithelial cancer or primary peritoneal cancer.

Key facts

Study ID

NCT00030706

Run by

Montefiore Medical Center

Starts

2004-11-01

Last updated by the study team

2018-09-28

Who can join

Age: 18 and older, up to 75. Sex: female. Healthy volunteers: not accepted.

Where it is running

• Albert Einstein Cancer Center at Albert Einstein College of Medicine — The Bronx, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.